Promoting nucleic acid detection, Desheng and Zhiyuan reached a strategic cooperation relationship
Recently, Hubei New Desheng Material Technology Co., Ltd. and Wuhan Zhiyuan Medical Technology Co., Ltd. reached a strategic cooperation agreement on the production of virus sampling tubes. Both parties will give full play to their respective advantages in Virus Transport Medias, sampling tubes, filling and packaging, and technical support. , Quality testing, after-sales service and other aspects of comprehensive and in-depth cooperation to jointly create a new sample of the in vitro diagnostic industry.
Wuhan Zhiyuan Medical Technology Co., Ltd. was established on November 11, 1996, located in Jiufeng Street, Canglong Island Office, Jiangxia Economic Development Zone, Wuhan City, and its subsidiary is located in Gedian Optical Valley United Technology City, Ezhou City, Hubei Province. Liu Futao. The business scope includes R&D, production, sales of Class I, Class II, Class III medical devices, biological health products, medical plastic products, medical hygiene materials, medical disinfectants, mechanical equipment and related technical services; import and export trade. (Projects that are subject to approval according to law can only be operated after approval by the relevant departments). Currently, the production of virus sampling tubes is mainly carried out by the subsidiaries of the United Science and Technology City. The daily output of the 100,000-level automated dust-free workshop in its factory area can reach 100,000 to 200,000 virus sampling tubes, the operators are well-trained old employees, Desheng company will appoint quality inspectors to conduct spot checks on finished products every day. .
Hubei Xindesheng Material Technology Co., Ltd., legal representative Wang Anqi, with a registered capital of 10 million yuan, is located in Optics Valley United Technology City, Gedian Development Zone, Ezhou City. Business scope: R&D, production and sales of polymer materials and biological agents; goods And technology import and export and agency import and export business (projects subject to approval in accordance with the law, can only carry out business activities after approval by relevant departments). Desheng Biochemical specializes in the research, development, production and sales of blood collection tube additives, in vitro diagnostic reagents, buffers and luminescent substrates. In terms of blood collection tube additives, it has formed independent intellectual property rights and professional production research and development capabilities. Provide products and raw material solutions for more than 100 domestic and foreign production companies. As an in vitro diagnostic reagent raw material manufacturer, Desheng has great advantages in the development of Virus Transport Medias. The production of inactivated and non-inactivated viruses is preserved. The liquid can provide the necessary transportation medium for nucleic acid detection, and the properties are stable, and it meets the relevant national standards after clinical testing.
The two companies have conducted in-depth cooperation on the production of virus sampling tubes. Desheng is mainly responsible for the development and production of Virus Transport Medias and the quality testing of Zhiyuan's finished products, while Zhiyuan is responsible for the supply of raw materials for virus sampling tubes and preservation solutions. In the packaging and packaging work, the two companies supervise each other during the production process, and communicate and deal with problems in time to ensure that the product quality meets the corresponding standards.
3- (cyclohexylamine) -1-propanesulfonic acid, abbreviated as CAPS, is an important buffer and laboratory reagent. At present, the demand for it in the market is gradually increasing. In view of industry competition, various manufacturers are constantly adjusting prices to attract customer flow. So what is the connection between its price adjustment and? This article will answer everyone's doubts.